期刊文献+

139例胃肠道间质瘤患者临床疗效及预后分析 被引量:10

Clinical efficacy and prognosis of 139 patients with gastric stromal tumor
下载PDF
导出
摘要 目的探讨胃肠道间质瘤(GISTs)的外科治疗效果及其影响因素。方法回顾性分析2008~2014年在长海医院接受手术治疗并经病理证实的139例GISTs患者的相关临床资料,采用Kaplan-Meier法绘制生存曲线(log-rank检验)和Cox多因素回归分析影响因素。结果139例患者均接受手术切除,随访率达87.77%。全组患者术后1、3、5年生存率为96.72%、85.25%、77.87%;1、3、5年无疾病进展生存率95.08%、81.97%、77.87%。单因素分析影响GISTs总生存时间以及无疾病进展生存时间的因素为肿瘤大小、核分裂像、肿瘤危险分级(P<0.05);多因素Cox回归分析显示,患者术后生存率与肿瘤危险分级、核分裂像相关(P<0.05)。采用腹腔镜手术术中手术时间缩短,出血量减少(P<0.05);术后进食时间以及出院时间明显早于开腹手术方式的患者(P<0.05)。结论GISTs治疗以外科手术为主,肿瘤危险分级、核分裂像是影响GISTs患者术后预后的独立危险因素。腹腔镜下行GISTs切除术,患者创伤小,恢复快。 Objective To analyze the outcome of the patients with gastric gastrointestinal stromal tumor (GIST) after surgical treatment and identify the associated risk factors. Methods 139 gastric GISTs patients with confirmed pathologically were included from 2008 to 2014. Their clinical datas were retrospectively analyzed. Results The follow up rate was 87.77%. The overall survival( OS) of 1,3 and 5 years were 96.72%,85.25% and 77.87%,The PFS of 1,2,3 years were 95.08%,81.97%,77.87% respectively. Single factor survival analysis showed that OS had significant association with tumor size,mitotic index and tumor risk grading. However,only tumor risk grading,karyokinesis were associated with survival rates by Cox regression multivariable analysis. Conclusion Surgery is the main treatment for gastric GIST. tumor risk grading,karyokinesis are potential prognostic factor of gastric GISTs.Laparoscopic reception of gastric stromal tumors can be performed safely and patients can recover quickly.
作者 郑瑞 庞涛 张新 聂明明 印慨 Zheng Rui;Pang Tao;Zhang Xin(Department of Gastrointsetinal Surgery,Shanghai Changhai Hospital,Shanghai 200433,China)
出处 《中华保健医学杂志》 2019年第4期338-340,共3页 Chinese Journal of Health Care and Medicine
关键词 胃肠道间质瘤 外科手术 腹腔镜 预后 Gastrointestinal stromal tumors Surgical procedures Laparoscopy Prognosis
  • 相关文献

参考文献2

二级参考文献15

  • 1Cristina R. Antonescu,Salvatore Romeo,Lei Zhang,Khedoudja Nafa,Jason L. Hornick,Gunnlaugur Petur Nielsen,Mari Mino-Kenudson,Hsuan-Ying Huang,Juan-Miguel Mosquera,Paolo A. Dei Tos,Christopher D.M. Fletcher.Dedifferentiation in Gastrointestinal Stromal Tumor to an Anaplastic KIT-negative Phenotype: A Diagnostic Pitfall: Morphologic and Molecular Characterization of 8 Cases Occurring Either De Novo or After Imatinib Therapy[J]. The American Journal of Surgical Pathology . 2013 (3)
  • 2Katarina Sj?lund,Anna Andersson,Erik Nilsson,Ola Nilsson,H?kan Ahlman,Bengt Nilsson.Downsizing Treatment with Tyrosine Kinase Inhibitors in Patients with Advanced Gastrointestinal Stromal Tumors Improved Resectability[J]. World Journal of Surgery . 2010 (9)
  • 3MarcoNovelli,SabrinaRossi,ManuelRodriguez‐Justo,PhilippeTaniere,BeatriceSeddon,LuisaToffolatti,ChiaraSartor,Pancras C WHogendoorn,RafSciot,MartineVan Glabbeke,JaapVerweij,Jean YvesBlay,PeterHohenberger,AdrienneFlanagan,Angelo PDei Tos.DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours[J]. Histopathology . 2010 (2)
  • 4Heikki Joensuu.Risk stratification of patients diagnosed with gastrointestinal stromal tumor[J]. Human Pathology . 2008 (10)
  • 5Yoshinari Mochizuki,Yasuhiro Kodera,Michitaka Fujiwara,Seiji Ito,Yoshitaka Yamamura,Akira Sawaki,Kenji Yamao,Tomoyuki Kato.Laparoscopic Wedge Resection for Gastrointestinal Stromal Tumors of the Stomach: Initial Experience[J]. Surgery Today . 2006 (4)
  • 6Bosman FT,Carneiro F,Hruban RH,et al.WHO classification of tumours of the digestive system. Journal of Women s Health . 2010
  • 7H. Joensuu,M. Eriksson,J. Hatrmann,K. Sundby Hall,J. Schutte,A. Reichardt,M. Schlemmer,E. Wardelmann,G. Ramadori,S. Al-Batran,B. E. Nilsson,O. Monge,R. Kallio,M. Sarlomo-Rikala,P. Bono,M. Leinonen,P. Hohenberger,T. Alvega.Twelve versus 36 months of adjuvant imatinib (IM) as treatment of operable GIST with a high risk of recurrence: Final results of a randomized trial (SSGXVIII/AIO). ASCO Meeting Abstracts . 2011
  • 8Bosman FT,Carneiro F,Hruban RH,et al.WHO classification of tumours of the digestive system. Journal of Women s Health . 2010
  • 9王春萌,师英强,吴江宏,朱蕙燕,成宇帆.伊马替尼治疗胃肠间质瘤疗效评估标准研究[J].中国实用外科杂志,2011,31(4):308-310. 被引量:4
  • 10曹晖,汪明.双镜联合技术在胃肠道间质瘤诊治中的应用及评价[J].中国实用外科杂志,2012,32(1):63-65. 被引量:11

共引文献79

同被引文献80

引证文献10

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部